DRIO Material Contracts | DarioHealth Corp.

DarioHealth Corp. Material Contracts

Every material contract the company filed as Exhibit 10 (executive pay plans, credit agreements, supplier and indemnity agreements), newest first, with the filing's own description.

2026-08-21: Form 8-K; Exhibit 10.2; Description Consulting Agreement, by and between DarioHealth Corp. and Steven Nelson, dated August 20, 2026..
2026-08-21: Form 8-K; Exhibit 10.1; Description Separation Agreement, by and between DarioHealth Corp. and Steven Nelson, dated August 20, 2026..
2026-07-22: Form 8-K; Exhibit 10.2; Description Placement Agency Agreement, dated July 22, 2026.
2026-07-22: Form 8-K; Exhibit 10.1; Description Form of Securities Purchase Agreement.

Filed	Form	Exhibit	Description
2026-08-21	8-K	10.2	Consulting Agreement, by and between DarioHealth Corp. and Steven Nelson, dated August 20, 2026.
2026-08-21	8-K	10.1	Separation Agreement, by and between DarioHealth Corp. and Steven Nelson, dated August 20, 2026.
2026-07-22	8-K	10.2	Placement Agency Agreement, dated July 22, 2026
2026-07-22	8-K	10.1	Form of Securities Purchase Agreement
2026-03-30	8-K	10.1	Sales Agreement between the Company and A.G.P./Alliance Global Partners, dated March 30, 2026
2025-11-13	10-Q	10.2	Form of Second Amended and Restated Lock-Up Agreement.
2025-11-10	8-K	10.1	Credit Agreement Amendment, dated November 5, 2025, by and among the Company, as borrower, Callodine Commercial Finance, LLC, as agent and lender, and the financial institutions party thereto from time to time as lenders.
2025-09-25	8-K	10.1	Form of Securities Purchase Agreement
2025-05-29	8-K	10.1	Form of Amended and Restated Lock-Up Agreement
2025-05-14	10-Q	10.4	Amendment to Offer Letter dated May 29, 2024, by and between DarioHealth Corp. and Steven Nelson.
2025-05-06	8-K	10.1	Credit Agreement, dated April 30, 2025, by and among the Company, as borrower, Callodine Commercial Finance, LLC, as agent and lender, and the financial institutions party thereto from time to time as lenders.
2025-04-21	8-K	10.2	Termination of Employment and Separation Agreement, dated April 18, 2025, between DarioHealth Corp. and Zvi Ben-David
2025-04-21	8-K	10.1	Personal Employment Agreement, dated April 18, 2025, between DarioHealth Corp. and Chen Franco-Yehuda
2025-03-10	10-K	10.23	Redemption Agreement by and between DarioHealth Corp. and Richard Allan Anderson dated June 9, 2022.
2025-02-27	8-K	10.3	Second Amendment to Consulting Agreement by and between the Company and NearWater Growth, LLC, dated February 27, 2025.
2025-02-27	8-K	10.2	Amendment to Consulting Agreement by and between the Company and NearWater Growth, LLC, dated June 5, 2023.
2025-02-27	8-K	10.1	Consulting Agreement by and between the Company and NearWater Growth, LLC, dated September 3, 2021.
2025-01-10	8-K	10.1	Series D Securities Purchase Agreement.
2024-12-18	8-K	10.3	Second Amendment to Loan and Security Agreement and Supplement, dated December 17, 2024, by and among DarioHealth Corp., PsyInnovations, Inc., LabStyle Innovation Ltd., Avenue Venture Opportunities Fund II, L.P. and Avenue Venture Opportunities Fund, L.P.
2024-12-18	8-K	10.2	Form of Lock-Up Agreement
2024-12-18	8-K	10.1	Series D Securities Purchase Agreement
2024-06-05	8-K	10.1	Offer Letter dated May 29, 2024, by and between DarioHealth Corp. and Steven Nelson
2024-04-05	8-K	10.1	Amendment to Employment Agreement by and between LabStyle Innovation Ltd. and Zvi Ben-David, dated April 4, 2024.
2024-03-28	10-K	10.35	Personal Employment Agreement, dated February 16, 2024, between LabStyle Innovation Ltd. and Tomer Ben-Kiki
2024-03-28	10-K	10.34	Personal Employment Agreement, dated February 16, 2024, between DarioHealth Corp. and Tomer Ben-Kiki
2024-03-28	10-K	10.24	Form of Preferred Exchange Agreement by and between DarioHealth Corp. and certain holders of Series A-1 Preferred Stock, dated September 20, 2022.
2024-03-28	10-K	10.23	Redemption Agreement by and between DarioHealth Corp. and Richard Allan Anderson dated June 9, 2022.
2024-02-21	8-K	10.6	First Amendment to Loan and Security Agreement and Supplement, dated February 15, 2024, by and among DarioHealth Corp., PsyInnovations, Inc., LabStyle Innovation Ltd., Avenue Venture Opportunities Fund II, L.P. and Avenue Venture Opportunities Fund, L.P.
2024-02-21	8-K	10.5	Amendment No. 1 to Placement Agency Agreement dated January 31, 2024
2024-02-21	8-K	10.4	Placement Agency Agreement dated December 28, 2023
2024-02-21	8-K	10.3	Series C Securities Purchase Agreement
2024-02-21	8-K	10.2	Lock Up/Leak Out Agreement dated February 15, 2024, by and among DarioHealth Corp., Titan Trust 2024 I, a Delaware statutory trust, and WhiteHawk Capital Partners LP, a Delaware limited partnership
2024-02-21	8-K	10.1	Agreement and Plan of Merger dated February 15, 2024, by and among DarioHealth Corp., Twill Merger Sub, Inc., Twill, Inc. and Bilal Khan solely in his capacity as holders’ representative
2023-08-10	10-Q	10.1	Amended and Restated Exclusive Preferred Partner, Co-Promotion, Development Collaboration and License Agreement by and between Sanofi US Services, Inc. and DarioHealth Corp., dated July 10, 2023.
2023-05-05	8-K	10.4	Form of Securities Purchase Agreement for Series B-3 Preferred Stock
2023-05-05	8-K	10.3	Form of Preferred Agreement with Series A-1 Convertible Preferred Stockholders
2023-05-05	8-K	10.2	Loan and Security Agreement, dated May 1, 2023, by and among the Company, as borrower, and Avenue Venture Opportunities Fund II, L.P., as lender.
2023-05-05	8-K	10.1	Form of Securities Purchase Agreement for Series B, Series B-1, and Series B-2 Preferred Stock
2023-03-09	10-K	10.24	Form of Preferred Exchange Agreement by and between DarioHealth Corp. and certain holders of Series A-1 Preferred Stock, dated September 20, 2022.
2023-03-09	10-K	10.23	Redemption Agreement by and between DarioHealth Corp. and Richard Allan Anderson dated June 9, 2022.
2023-01-27	8-K	10.1	Termination of Employment and Separation Agreement dated January 23, 2023 by and between Dror Bacher and Labstyle Innovation Ltd.
2022-08-15	10-Q	10.2	Amendment to Agreement and Plan of Merger by and between the Company and certain representatives of the former equity holders of PsyInnovations, Inc., dated July 7, 2022.
2022-08-15	10-Q	10.1	Agreement and Plan of Merger by and among DarioHealth Corp., WF Merger Sub, Inc., PsyInnovations, Inc., and certain representatives of the former equity holders of PsyInnovations, Inc., dated May 15, 2021.
2022-06-13	8-K	10.3	Registration Rights Agreement, dated June 9, 2022, by and between the Company and OrbiMed Royalty and Credit Opportunities III, LP.
2022-06-13	8-K	10.2	Pledge and Security Agreement, dated June 9, 2022, by and among the Company, Labstyle Innovation Ltd, Upright Technologies, Inc., Psyinnovations, Inc., and OrbiMed Royalty and Credit Opportunities III, LP.
2022-06-13	8-K	10.1	Credit Agreement, dated June 9, 2022, by and among the Company, as borrower, and OrbiMed Royalty and Credit Opportunities III, LP, as lender.
2022-05-12	10-Q	10.2	Technology Purchase Agreement by and among Physimax Technologies Ltd., Labstyle Innovation Ltd. and DarioHealth Corp., dated January 18, 2022.
2022-05-12	10-Q	10.1	Exclusive Preferred Partner, Co-Promotion, Development Collaboration and License Agreement by and between Sanofi US Services, Inc. and DarioHealth Corp., dated February 28, 2022.
2022-03-02	8-K	10.1	Form of Securities Purchase Agreement
2021-03-09	10-K	10.20	Share Purchase Agreement by and among DarioHealth Corp., LabStyle Innovation Ltd., Upright Technologies Ltd., Vertex C (C.I.) Fund L.P., as holder representative and certain holders of Upright’s outstanding securities, dated January 26, 2021.* ^
2021-03-09	10-K	10.10	Employment Agreement, effective as of February 1, 2021, between Oded Cohen and Upright Technologies Ltd. + *
2021-02-04	8-K	10.1	Employment Agreement by and between LabStyle Innovation Ltd. and Oded Cohen, dated February 1, 2021
2021-01-28	8-K	10.2	Form of Registration Rights Agreement
2021-01-28	8-K	10.1	Form of Securities Purchase Agreement
2020-03-17	10-K	10.16	Representative Form of Indemnification Agreements between DarioHealth Corp. and each of its directors and officers+*
2020-03-17	10-K	10.15	Conditional Stock Option Agreement between DarioHealth Corp. and Richard Anderson*
2020-03-17	10-K	10.14	Stock Option Agreement between DarioHealth Corp. and Richard Anderson*
2020-03-17	10-K	10.13	Amendment No. 1 to Amended and Restated Employment Agreement, dated as of February 12, 2020, between Erez Raphael and LabStyle Innovation Ltd. + *
2020-03-17	10-K	10.12	Placement Agency Agreement by and between DarioHealth Corp. and Aegis Capital Corp. dated October 22, 2019*
2020-03-17	10-K	10.11	Form of Registration Rights Agreement for Series A, Series A-1, Series A-2, Series A-3 and Series A-4 Preferred Stock*
2020-03-17	10-K	10.10	Form of Subscription Agreement for Series A, Series A-1, Series A-2, Series A-3 and Series A-4 Preferred Stock*
2020-02-05	8-K	10.1	Amendment to the Company’s Amended and Restated 2012 Equity Incentive Plan.
2019-11-06	8-K	10.1	Amendment to the Company’s Amended and Restated 2012 Equity Incentive Plan.
2018-12-18	8-K	10.1	Form of Securities Purchase Agreement
2018-11-29	8-K	10.1	Amendment to the Company’s Amended and Restated 2012 Equity Incentive Plan.
2018-05-21	8-K	10.1	Amendment to the Company’s Amended and Restated 2012 Equity Incentive Plan.
2018-03-19	10-K	10.37	Form of Securities Purchase Agreement for the purchase of shares of Series C Convertible Preferred and/or Common Stock*
2018-03-19	10-K	10.36	Form of Securities Purchase Agreement for the purchase of shares of Common Stock*
2017-12-05	8-K	10.1	Amendment to the Company’s Amended and Restated 2012 Equity Incentive Plan.
2017-11-14	10-Q	10.1	Form of Warrant Exchange Agreement.
2017-08-25	8-K/A	10.2	Form of Securities Purchase Agreement for the purchase of shares of Preferred Stock
2017-08-25	8-K/A	10.1	Form of Securities Purchase Agreement for the purchase of shares of Common Stock
2017-07-26	8-K	10.2	Employment Agreement, dated as of September 22, 2013, and as amended on August 1, 2014, April 27, 2015 and May 1, 2016, between Dror Bacher and Labstyle Innovation Ltd.
2017-07-26	8-K	10.1	Amended and Restated Employment Agreement, dated as of July 25, 2017, between Erez Raphael and LabStyle Innovation Ltd.
2016-08-11	10-Q	10.2	Agreement between the Company, Dicilyon Consulting and Investment Ltd. and David Edery, dated August 10, 2016.
2016-07-28	8-K	10.1	Form of Warrant Amendment Agreement
2016-03-09	8-K	10.1	Form of Securities Purchase Agreement
2016-02-08	10-K	10.23	Form of Securities Purchase Agreement by and among the Company and the Purchasers named therein in connection with the Company’s December 2015 Private Placement
2016-02-08	10-K	10.17	Amendment No. 1 to 2012 Equity Incentive Plan of the Company+
2015-11-19	8-K	10.1	Form of Securities Purchase Agreement
2015-11-02	8-K	10.1	Form of Warrant Replacement Agreement
2015-08-12	10-Q	10.3	Form of Securities Purchase Agreement.
2015-06-16	8-K	10.1	Amendment No. 3 to the 2012 Equity Incentive Plan.
2015-05-20	8-K	10.1	Form of Warrant Exercise and Replacement Agreement
2015-02-26	8-K	10.2	Form of Registration Rights Agreement, dated as of February 25, 2015, by and among the Company and the Buyers named therein.
2015-02-26	8-K	10.1	Form of Securities Purchase Agreement, dated as of February 25, 2015, by and among the Company and the Buyers named therein.
2015-01-09	8-K	10.1	Personal Employment Agreement, dated January 8, 2015, by and between LabStyle Innovation Ltd. and Zvi Ben David.
2014-09-24	8-K	10.1	Form of Securities Purchase Agreement, dated as of September 23, 2014, by and among the Company and the Purchasers named therein.
2014-08-18	8-K	10.1	Form of Amendment and Exchange Agreement entered into between the Company and the several Buyers on August 15, 2014.
2014-06-18	8-K	10.1	AMENDMENT TO EQUITY INCENTIVE PLAN
2014-02-13	8-K	10.1	Securities Purchase Agreement, dated as of February 12, 2014, by and among the Company and the Buyers named therein.
2014-02-03	8-K	10.1	Agreement, dated January 28, 2014 and effective December 31, 2013, between the Company and Dr. Oren Fuerst.
2013-11-29	8-K	10.1	Employment Agreement, dated November 26, 2013, by and among the Company and Gadi Levin
2013-09-06	8-K	10.3	Amendment No.2 to Personal Employment Agreement, dated August 30, 2013, between the Company and Erez Raphael.
2013-09-06	8-K	10.2	Amendment No.1 to Personal Employment Agreement, dated April 1, 2013, between the Company and Erez Raphael.
2013-09-06	8-K	10.1	Personal Employment Agreement, dated October 11, 2012, between the Company and Erez Raphael.
2013-05-13	8-K	10.1	Form of Subscription Agreement between the Company and the Investors in the Offering.
2013-04-30	8-K	10.1	DISTRIBUTION AGREEMENT

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
CVRx, Inc. (CVRX)	United States	$0.067B	-2.62
FRACTYL HEALTH, INC. (GUTS)	United States	$0.075B	-1.18
TELA Bio, Inc. (TELA)	United States	$0.057B	-0.82
RenovoRx, Inc. (RNXT)	United States	$0.076B	-3.62
Xtant Medical Holdings, Inc. (XTNT)	United States	$0.053B
Spectral AI, Inc. (MDAI)	United States	$0.052B
Pulmonx Corp (LUNG)	United States	$0.082B	-1.16
Sensus Healthcare, Inc. (SRTS)	United States	$0.048B	-3.24
SkinHealth Systems Inc. (SKIN)	United States	$0.086B	-3.17
LENSAR, Inc. (LNSR)	United States	$0.087B	2.02